Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus. - Wikidata - wikimedia - TriplyDB

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q37643007

about

Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts.The microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study.Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.Role of cardiac MRI in diabetes.Myocardial T1 mapping: modalities and clinical applications.Established and emerging cardiovascular magnetic resonance techniques for prognostication and guiding therapy in heart failure.Cardiac MRI: a central prognostic tool in myocardial fibrosis.T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance.Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure.Aldosterone is associated with left ventricular hypertrophy in hemodialysis patients.Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders.Cardiovascular complications of type 2 diabetes in youth.Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.

P2860

Q33890276-4D6D9D04-D659-40A0-A2AA-A01EC4EDE6B9 Q34556389-3AF59C6F-9931-4BE2-8644-F909954C7227 Q34762461-2979A736-A3FE-4AFC-88F1-60159546A3DF Q37662894-5E795AAE-4C3A-4A9D-997C-BE7041D3E4EF Q37717684-94A8569F-7070-40F3-AE5D-38EEEC6525F8 Q38171866-05A3179C-DBF1-46FF-B031-386DC0FE253C Q38263089-A2555ABA-776D-4C56-8862-0A27208FBE6D Q38270769-77CC9416-EECC-41ED-A6A6-35B376682595 Q38373783-B4AD8984-01DD-40D1-8AEB-E0CD5F228749 Q38393182-687F1778-3225-4894-BD7C-2016F48437A7 Q38525979-A4EC465D-247C-4D81-8E18-1601686220E9 Q41514778-604C8729-A93E-4CEE-8CC7-D24D178D29B3 Q47285651-8565105F-E0AA-4B30-8083-7B21A70B9462

P2860

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q37643007

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

@en

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

@nl

type

label

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

@en

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

@nl

prefLabel

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

@en

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

@nl

P1433

Q37643007-05108F76-F55D-4F02-A1EB-F30061D86539

P1476

Q37643007-4C797766-DC64-4541-8A2C-FD0C405E2814

P2093

Q37643007-16EA86E4-3E28-42EE-ADE0-8F07C13CCA65

Q37643007-5FC84EDE-8B69-461F-BD33-306C1E5F6177

Q37643007-63545482-E6C7-43C5-BCAE-F17A9CDCA073

Q37643007-9E1EC178-FDCB-4F1F-BDBF-D948D0C2DC04

Q37643007-A8F45449-2CCB-4C05-AF56-3499CFD4490D

Q37643007-B3A7CB1B-509E-4CB3-8D46-96135BEBCAF1

Q37643007-B9EBCF97-BC70-42BE-AC58-2C73394E23A7

P2860

Q37643007-00749257-8A7D-49B2-982D-E576A5A6A825

Q37643007-04FB888B-2E83-49E3-A15A-6AFE6A286D27

Q37643007-10676694-E59C-47AD-A3EA-3BC627D7B757

Q37643007-2F86B5AA-8924-4A6F-9D68-0D3AC4C5BEA2

Q37643007-356E0124-8DCB-4CD4-8CD5-B5636C5C3AD1

Q37643007-3FDBA005-06F0-4480-8D1D-13F927EC534F

Q37643007-5BE31CAD-FEA0-47D1-99D1-1537017072E5

Q37643007-67EF4FC6-287E-4D38-B352-5EC4E0D934EE

Q37643007-697609C7-B428-412F-996B-A549B83C4E75

Q37643007-7BEFD1D4-3519-4CF0-B34B-BBD8198B95C1

P304

Q37643007-0E810880-E15F-431A-AFA3-42F9D47B7549

P31

Q37643007-94C528E0-7935-4EC7-8507-EA063EB7B07E

P356

Q37643007-D391904C-0C08-41FD-8621-0F4622A3E22C

P407

Q37643007-6B0ED83C-20F2-42ED-B951-CA5E3AEC3B21

P433

Q37643007-454CAB0B-83C6-4CF8-8F89-6C873B0797FE

P478

Q37643007-E5368228-7EB9-4892-A5D8-7510B0944EA1

P50

Q37643007-1809D27E-B1CB-43CE-8444-04E42AEADFA3

Q37643007-51927F6B-07A5-4BA9-8C4D-FD95E2C3EC0E

Q37643007-AF18602E-49AE-4439-BB59-2A03C3294D57

P577

Q37643007-C66F8151-1989-4C48-9931-A57DD17473E8

P5875

Q37643007-117A8131-ACAE-4F51-AE35-290C0D1D0F1E

P698

Q37643007-889CED56-043F-4378-9F70-B5A99E7DFB8B

P921

Q37643007-7FCA504D-2537-40B6-A08D-7BDFEA102667

Q37643007-EF39F074-3CB6-49D0-B9F3-C9B21F55EF0C

P932

Q37643007-538DDEE2-5A4F-4C75-B454-AECE862AC631

P356

J.AMJCARD.2013.02.060

P1433

American Journal of Cardiology

P1476

Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus.

@en

P2093

Gail K Adler

http://www.w3.org/2001/XMLSchema#string

Marcelo F Di Carli

http://www.w3.org/2001/XMLSchema#string

Rajesh Garg

http://www.w3.org/2001/XMLSchema#string

Ravi V Shah

http://www.w3.org/2001/XMLSchema#string

Raymond Y Kwong

http://www.w3.org/2001/XMLSchema#string

Todd S Perlstein

http://www.w3.org/2001/XMLSchema#string

Tomas G Neilan

http://www.w3.org/2001/XMLSchema#string

P2860

Standards of medical care in diabetes--2012

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease

Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy

Evidence for cardiomyopathy in familial diabetes mellitus.

The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study.

Left atrial passive emptying function during dobutamine stress MR imaging is a predictor of cardiac events in patients with suspected myocardial ischemia

Cell membrane-associated mineralocorticoid receptors? New evidence.

Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging.

P304

73-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2013.02.060

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Siddique A. Abbasi

Michael Jerosch-Herold

P577

2013-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236226980

http://www.w3.org/2001/XMLSchema#string

P698

23597770

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

type-2 diabetes

P932

3957437

http://www.w3.org/2001/XMLSchema#string